(Q77899832)

English

Alendronate increases spine and hip bone mineral density in women with postmenopausal osteoporosis who failed to respond to intermittent cyclical etidronate

scientific article published on 01 January 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916786%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Alendronate increases spine and hip bone mineral density in women with postmenopausal osteoporosis who failed to respond to intermittent cyclical etidronate (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916786%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

postmenopausal osteoporosis

1 reference

based on heuristic

inferred from title

author name string

N B Watts

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916786%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

P Becker

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916786%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

publication date

1 January 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916786%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916786%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916786%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916786%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

65-68

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916786%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900144-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900144-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900144-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900144-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclical etidronate in the treatment of postmenopausal osteoporosis: efficacy and safety after seven years of treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900144-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Estrogen therapy and osteoporosis: principles & practice

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900144-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900144-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900144-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Intermittent cyclical etidronate treatment of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900144-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Statistical concepts in the interpretation of serial bone densitometry.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900144-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S8756-3282(98)00144-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916786%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916786%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77899832&oldid=1651794902"